Could a common sedative save lives and prevent delirium in older ICU patients?
NCT ID NCT06251375
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 18 times
Summary
This study looks at whether the sedative drug dexmedetomidine, given early to older patients (65+) on breathing machines in the ICU, can reduce deaths and confusion compared to a placebo. About 300 participants will receive either the drug or a dummy treatment, and researchers will track survival, days free of coma and delirium, and kidney health. The goal is to find a safer way to keep patients comfortable while on life support.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY INSUFFICIENCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mount Sinai Hospital
Toronto, Ontario, M5G 1X5, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.